Cargando…
Transcytosis in the blood–cerebrospinal fluid barrier of the mouse brain with an engineered receptor/ligand system
Crossing the blood–brain and the blood–cerebrospinal fluid barriers (BCSFB) is one of the fundamental challenges in the development of new therapeutic molecules for brain disorders because these barriers prevent entry of most drugs from the blood into the brain. However, some large molecules, like t...
Autores principales: | Méndez-Gómez, Héctor R, Galera-Prat, Albert, Meyers, Craig, Chen, Weijun, Singh, Jasbir, Carrión-Vázquez, Mariano, Muzyczka, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596253/ https://www.ncbi.nlm.nih.gov/pubmed/26491705 http://dx.doi.org/10.1038/mtm.2015.37 |
Ejemplares similares
-
Acrylamide exposure impairs blood-cerebrospinal fluid barrier function
por: Yao, Xue, et al.
Publicado: (2014) -
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
por: Georgieva, Julia V., et al.
Publicado: (2014) -
Nanomechanics of tip-link cadherins
por: Oroz, Javier, et al.
Publicado: (2019) -
A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding
por: Sade, Hadassah, et al.
Publicado: (2014) -
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
por: Pulgar, Victor M.
Publicado: (2019)